Early Access Programs (EAPs) and Named Patient Programs (NPPs) provide a pathway for patients with life-threatening ...

Gritstone bio's stock dropped 62% after releasing interim Phase II data on its neoantigen immunotherapy, GRANITE, in ...

The US Food and Drug Administration (FDA) yesterday released its fiscal year 2023 (FY23) Generic Drug User Fee Amendments ...

Spanish epigenetics firm Oryzon Genomics has announced the receipt of the official meeting minutes from a recent End-of-Phase ...

CAMP4 Therapeutics has announced a new research collaboration with BioMarin Pharmaceutical aimed at advancing novel therapeutics that increase protein levels by targeting regulatory RNA (regRNA) ...

Santhera Pharmaceuticals’ rose as much as 5% to .46 francs yesterday after it announced the outcome of the LIONHEART study, confirming vamorolone’s distinctive action also a a mineralocorticoid ...

Halda Therapeutics has appointed Christian Schade as president and CEO, bringing over 20 years of experience as the company ...

CSL Behring has received a positive recommendation from Spain's Interministerial Commission on the Pricing of Medicines (CIPM ...

USA-based Kailera Therapeutics today announced its launch as a clinical-stage biopharmaceutical company focused on advancing ...

Roche sees significant potential in the growing obesity market, estimating it could exceed $100 billion by 2030. During its ...

Following a positive a positive European Medicines Agency recommendation in July, the European Commission (EC) has now ...

Bristol Myers Squibb won a legal victory as a New York judge dismissed a $6.4 billion lawsuit filed by UMB Bank on behalf of ...